A trial HIV vaccine triggered elusive and essential antibodies in humans

Published on May 17, 2024

An HIV vaccine candidate triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.